Organ Function Assays - Medical Devices Pipeline Assessment, 2019

Published by Global Data on 1st November 2019 | Ref: 1461246 | This Product Is In Stock

$2500 | Single User
$5000 | Site License
$7500 | Enterprise License
$2500 | Single User
$5000 | Site License
$7500 | Enterprise License


Organ Function Assays - Medical Devices Pipeline Assessment, 2019


GlobalData's Medical Devices sector report, “Organ Function Assays - Medical Devices Pipeline Assessment, 2019" provides an overview of Organ Function Assays currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Organ Function Assays pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.


- Extensive coverage of the Organ Function Assays under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Organ Function Assays and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry

Reasons to buy

The report enables you to -

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Organ Function Assays under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

Table of Contents

1.1 List of Tables 4

1.2 List of Figures 5

2 Introduction 6

2.1 Organ Function Assays Overview 6

3 Products under Development 7

3.1 Organ Function Assays - Pipeline Products by Stage of Development 7

3.2 Organ Function Assays - Pipeline Products by Territory 8

3.3 Organ Function Assays - Pipeline Products by Regulatory Path 9

3.4 Organ Function Assays - Pipeline Products by Estimated Approval Date 10

3.5 Organ Function Assays - Ongoing Clinical Trials 11

4 Organ Function Assays - Pipeline Products under Development by Companies 12

4.1 Organ Function Assays Companies - Pipeline Products by Stage of Development 12

4.2 Organ Function Assays - Pipeline Products by Stage of Development 13

5 Organ Function Assays Companies and Product Overview 14

5.1 Boditech Med Inc Company Overview 14

5.2 China Medical Technologies Inc (Inactive) Company Overview 15

5.3 Cornell University Company Overview 18

5.4 Daxor Corp Company Overview 19

5.5 DSX Therapeutics LLC Company Overview 20

5.6 French National Institute of Health and Medical Research Company Overview 21

5.7 HepQuant Llc Company Overview 22

5.8 Humedics GmbH Company Overview 28

5.9 Merck Millipore Corp Company Overview 29

5.10 Myriad Genetics Inc Company Overview 30

5.11 Proteome Sciences Plc Company Overview 31

5.12 Radboud University Medical Centre Company Overview 32

5.13 Schnellgen, Inc Company Overview 33

6 Organ Function Assays- Recent Developments 34

6.1 Oct 01, 2019: Fortress Diagnostics announces £8m investment in new headquarters 34

6.2 Sep 25, 2019: Myriad Genetics expands Board of Directors with two additional members 34

6.3 Aug 29, 2019: Siemens Healthineers announces new Canadian leadership 35

6.4 Aug 27, 2019: Chris Cournoyer joins CareDx Board of Directors 36

6.5 Aug 13, 2019: Myriad Genetics reports fiscal fourth-quarter and full-year 2019 financial results 36

6.6 Aug 01, 2019: CareDx reports second quarter 2019 results 38

6.7 Jul 29, 2019: Siemens Healthineers continues to drive growth forward 39

6.8 Jul 29, 2019: Changes in the Managing Board of Siemens Healthineers 41

6.9 Jul 02, 2019: Grace Colon succeeds Amy Abernethy on the CareDx Board 41

6.10 May 08, 2019: CareDx reports first quarter 2019 results 42

6.11 May 07, 2019: Myriad Genetics reports fiscal third-quarter 2019 financial results 43

6.12 May 02, 2019: Siemens Healthineers posts strong revenue and profit growth in the second quarter 44

6.13 Apr 04, 2019: HepQuant’s Disease Severity Index (DSI) demonstrates hepatic functional improvement in high percentage of NASH patients treated with obeticholic acid: Results from INTERCEPT 747-117 45

6.14 Mar 06, 2019: CareDx reports fourth quarter and FY 2018 results 46

6.15 Mar 04, 2019: Daxor Announces Rise in Kit Sales and Files Form N-CSR For 2018 48

6.16 Feb 20, 2019: Keith Hoffman joins HepQuant as Clinical Lab Manager 48

6.17 Feb 14, 2019: First patient enrolled in a pivotal trial of the HepQuant SHUNT Liver Diagnostic Test 49

6.18 Feb 11, 2019: Siemens Healthineers to invest EUR 350 million in new Campus Forchheim 49

6.19 Feb 05, 2019: Myriad Genetics reports fiscal second-quarter 2019 financial results 50

6.20 Jan 23, 2019: Proteome Sciences: Year-end trading update 51

6.21 Jan 07, 2019: CareDx Reports Preliminary Fourth Quarter and Full Year 2018 Financial Results 52

6.22 Dec 31, 2018: Myriad Genetics announced its former CEO Peter Durkee Meldrum passed away 54

6.23 Dec 17, 2018: CareDx Director Dr. Amy Abernethy Resigns Board Seat to Become Principal Deputy Commissioner of the FDA 55

6.24 Dec 04, 2018: 10 Billion Lab Tests and Growing: Siemens Healthineers Mass. Manufacturing Expansion Largely Completed 55

6.25 Dec 04, 2018: 10 billion lab tests and growing: Siemens Healthineers mass. manufacturing expansion largely completed 56

6.26 Nov 26, 2018: CareDx names Reginald Seeto, MB.BS, as president and chief business officer 57

6.27 Nov 26, 2018: CareDx strengthens executive leadership team with the appointment of Reginald Seeto, MB.BS, as President and Chief Business Officer 57

6.28 Nov 09, 2018: HepQuant receives IDE approval from U.S. FDA to initiate clinical trial of the SHUNT Liver Diagnostic Kit 58

6.29 Nov 09, 2018: Mayo Clinic elects Kent Thielen, M.D., CEO of its Florida operations; Mayo's board of trustees also names two new members 58

6.30 Nov 08, 2018: CareDx reports third quarter results 61

6.31 Nov 06, 2018: Proteome Sciences: Trading update confirmation of preferred provider status 62

6.32 Nov 05, 2018: Siemens Healthineers with strong finish in fourth quarter, full year targets for fiscal 2018 achieved 63

7 Appendix 65

7.1 Methodology 65

7.2 About GlobalData 68

7.3 Contact Us 68

7.4 Disclaimer 68

Additional Details


Global Data

Publisher Information


1461246 | GDME0807EPD

Number of Pages


Report Format


Related Reports

Date Published
Price From

This report is published by Global Data

Global Data deliver comprehensive, detailed market intelligence that provides a definitive picture of the markets they serve. Their data is complete, detailed, global and completely cross-country comparable.

With different types of data other providers don’t provide, our clients can access a variety of tools that add context to our core data including innovation tracking, sentiment analysis, price monitoring, M&A tracking, competitor intelligence, and city-level intelligence.

Download Free Report Summary PDF

Organ Function Assays - Medical Devices Pipeline Assessment, 2019 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types


Buy now using our secure payment system.